Cover Image
市場調查報告書

ANCA相關血管炎:全球臨床實驗檢討

Anca Vasculitis Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 316095
出版日期 內容資訊 英文 68 Pages
訂單完成後即時交付
價格
Back to Top
ANCA相關血管炎:全球臨床實驗檢討 Anca Vasculitis Global Clinical Trials Review, H2, 2014
出版日期: 2014年09月30日 內容資訊: 英文 68 Pages
簡介

本報告提供ANCA相關血管炎的臨床試驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床試驗的主要製藥企業及研究機關簡介等資訊。

簡介

  • ANCA相關血管炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:免疫疾病治療藥臨床實驗中,ANCA相關血管炎治療藥所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:ANCA相關血管炎治療藥的免疫疾病治療藥臨床實驗中,比率

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

參與ANCA相關血管炎治療藥臨床實驗的主要企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • GlaxoSmithKline plc
    • ChemoCentryx, Inc.
    • Anthera Pharmaceuticals, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Assistance Publique - Hopitaux de Paris
    • 衛生署
    • Cambridge University Hospitals NHS Foundation Trust
    • University of Pennsylvania
    • University of Oxford
    • Mayo Clinic
    • University Hospitals Birmingham NHS Foundation Trust
    • Shanghai Jiao Tong University
    • University of Schleswig-Holstein
    • University of Edinburgh

5個有代表性的臨床實驗簡介

附錄

目錄

GlobalData's clinical trial report, "Anca Vasculitis Global Clinical Trials Review, H2, 2014" provides data on the Anca Vasculitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anca Vasculitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anca Vasculitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Anca Vasculitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Anca Vasculitis to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Anca Vasculitis to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Anca Vasculitis
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Anca Vasculitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • ChemoCentryx, Inc.
      • Clinical Trial Overview of ChemoCentryx, Inc.
      • Anthera Pharmaceuticals, Inc.
      • Clinical Trial Overview of Anthera Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • Ministry of Health, Labour and Welfare, Japan
      • Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan
      • Cambridge University Hospitals NHS Foundation Trust
      • Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust
      • University of Pennsylvania
      • Clinical Trial Overview of University of Pennsylvania
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • University Hospitals Birmingham NHS Foundation Trust
      • Clinical Trial Overview of University Hospitals Birmingham NHS Foundation Trust
      • Shanghai Jiao Tong University
      • Clinical Trial Overview of Shanghai Jiao Tong University
      • University of Schleswig-Holstein
      • Clinical Trial Overview of University of Schleswig-Holstein
      • University of Edinburgh
      • Clinical Trial Overview of University of Edinburgh
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Anca Vasculitis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Anca Vasculitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Anca Vasculitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Anca Vasculitis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Anca Vasculitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Anca Vasculitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Anca Vasculitis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Anca Vasculitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Anca Vasculitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Anca Vasculitis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Anca Vasculitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Anca Vasculitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Anca Vasculitis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Anca Vasculitis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Anca Vasculitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by ChemoCentryx, Inc., 2014*
  • Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals, Inc., 2014*
  • Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Health, Labour and Welfare, Japan, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals Birmingham NHS Foundation Trust, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Jiao Tong University, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Schleswig-Holstein, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Edinburgh, 2014*

List of Figures

  • Anca Vasculitis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Anca Vasculitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Anca Vasculitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Anca Vasculitis to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Anca Vasculitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Anca Vasculitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Anca Vasculitis to Immunology Clinical Trials, E7 Countries (%), 2014*
  • Anca Vasculitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Anca Vasculitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Anca Vasculitis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Anca Vasculitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Anca Vasculitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Anca Vasculitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Anca Vasculitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top